Summary of Purpose
This is a pilot randomized control trial (RCT) to explore the possible beneficial effect of a novel combination therapy consisting of molecular hydrogen H2 plus minocycline ("H2M"), on neurological recovery after acute ischemic stroke.Read More →
The following dates are available for this trial. Trial information last updated on 24 October 2017.
|2 Aug 2017||20 Oct 2017||2 Aug 2019||2 Nov 2019||1 Oct 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
Interventions See All